HTG Molecular Diagnostics IPO Research Information

HTG Molecular Diagnostics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on HTG Molecular Diagnostics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
HTG Molecular Diagnostics	HTGM - NASDAQ	$13.00-$15.00	$14.00	$14.00	3.6 million	5/6/2015
Underwriter(s): Leerink Partners
Co-Manager(s): Canaccord Genuity, JMP Securities
Industry: Health Care
Filing(s): Filed 2014-12-30 Terms Added 2015-04-28

HTG Molecular Diagnostics Quote & Chart - Click for current quote - HTGM

About HTG Molecular Diagnostics (adapted from HTG Molecular Diagnostics prospectus):
They are a commercial stage company that developed and markets a novel technology platform to facilitate the routine use of complex molecular profiling.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "HTGM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.